Susquehanna International Group’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,265
Closed -$108K 12724
2022
Q4
$108K Sell
1,265
-310
-20% -$27.9K ﹤0.01% 10893
2022
Q3
$146K Sell
1,575
-660
-30% -$70.8K ﹤0.01% 11279
2022
Q2
$274K Sell
2,235
-2,050
-48% -$241K ﹤0.01% 9809
2022
Q1
$500K Buy
4,285
+630
+17% +$104K ﹤0.01% 8970
2021
Q4
$948K Buy
3,655
+85
+2% +$25.9K ﹤0.01% 7441
2021
Q3
$975K Buy
3,570
+2,235
+167% +$645K ﹤0.01% 7619
2021
Q2
$570K Buy
1,335
+160
+14% +$60.9K ﹤0.01% 9292
2021
Q1
$453K Buy
+1,175
New +$529K ﹤0.01% 9706

Other funds holding DRIO

Susquehanna International Group's DRIO Position: Q1 2025 in Review

Susquehanna International Group sold out of DarioHealth (DRIO) in Q1 2025, closing a stake of 1,088 shares — an estimated $17.1K sold.

Susquehanna International Group first reported a position in DRIO in Q4 2017 and held it in 18 quarters. The position peaked at $866K in Q3 2021. 42 funds tracked by Wall St. Rank hold DRIO as of Q1 2025.

  • Susquehanna International Group reported no remaining DarioHealth position as of Q1 2025 after selling out during the quarter.
  • Susquehanna International Group sold 1,088 DarioHealth shares in Q1 2025, an estimated $17.1K.
  • Susquehanna International Group first reported a position in DarioHealth in Q4 2017 and held it in 18 quarters.
  • Susquehanna International Group's DarioHealth position peaked at $866K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held DarioHealth as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.